P. falciparum Infection Durations and Infectiousness Are Shaped by Antigenic Variation and Innate and Adaptive Host Immunity in a Mathematical Model

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Eckhoff, Philip ^a  

^a Intellectual Ventures   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGENIC VARIATION; ARTICLE; CELL POPULATION; COMPUTER MODEL; CYTOKINE PRODUCTION; DISEASE DURATION; GAMETOCYTE; HOST PARASITE INTERACTION; INFLAMMATION; INNATE IMMUNITY; MALARIA FALCIPARUM; MATHEMATICAL MODEL; MOSQUITO; PARASITE CLEARANCE; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PROTIST LIFE CYCLE STAGE; REINFECTION; SIMULATION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, PROTOZOAN; CULICIDAE; FEMALE; IMMUNITY, INNATE; MALARIA, FALCIPARUM; MALE; MODELS, IMMUNOLOGICAL; PARASITEMIA; PLASMODIUM FALCIPARUM; TIME FACTORS;

PLASMODIUM FALCIPARUM;

EID: 84866525030     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044950     Document Type: Article

References (107)

1. Filipe JA, Riley EM, Drakeley CJ, Sutherland CJ, Ghani AC, (2007) Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol 3: e255.
2. Tediosi F, Maire N, Smith T, Hutton G, Utzinger J, et al. (2006) An approach to model the costs and effects of case management of Plasmodium falciparum malaria in sub-saharan Africa. Am J Trop Med Hyg 75: 90-103.
3. Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, et al. (2010) Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies. PLoS Med 7: e1000324.
4. Smith T, Killeen GF, Maire N, Ross A, Molineaux L, et al. (2006) Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview. Am J Trop Med Hyg 75: 1-10.
5. Molineaux L, Gramiccia G (1980) The Garki Project: Research on the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa. Geneva: World Health Organization.
6. Molineaux L, Diebner HH, Eichner M, Collins WE, Jeffery GM, et al. (2001) Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitology 122: 379-391.
7. Simpson JA, Aarons L, Collins WE, Jeffery GM, White NJ, (2002) Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology 124: 247-263.
8. Metcalf CJE, Graham AL, Huijben S, Barclay VC, Long GH, et al. (2011) Partitioning Regulatory Mechanisms of Within-Host Malaria Dynamics Using the Effective Propagation Number. Science 333: 984-988.
9. McKenzie FE, Bossert WH, (1997) The dynamics of Plasmodium falciparum blood-stage infection. J Theor Biol 188: 127-140.
10. Maire N, Smith T, Ross A, Owusu-Agyei S, Dietz K, et al. (2006) A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. Am J Trop Med Hyg 75: 19-31.
11. Sama W, Dietz K, Smith T, (2006) Distribution of survival times of deliberate Plasmodium falciparum infections in tertiary syphilis patients. Trans R Soc Trop Med Hyg 100: 811-816.
12. Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GAT, (2006) The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. 22: 424-430.
13. Dietz K, Raddatz G, Molineaux L, (2006) Mathematical model of the first wave of Plasmodium falciparum asexual parasitemia in non-immune and vaccinated individuals. Am J Trop Med Hyg 75: 46-55.
14. Sherman IW (2005) The Life of Plasmodium: An Overview. In: Sherman IW, editor. Molecular Approaches to Malaria. Washington DC: ASM Press. 3-11.
15. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, et al. (2002) A proteomic view of the Plasmodium falciparum life cycle. Nature 419: 520-526.
16. Coatney GR, Collins WE, Warren M, Contacos PG (1971) The Primate Malarias. Washington DC: US Government Printing Office.
17. Ross R (1910) The prevention of malaria. New York,: E.P. Dutton & company. 2 p.l., vii-xx, 669 p.
18. Macdonald G (1957) The epidemiology and control of malaria. London, New York,: Oxford University Press. 201 p.
19. Anderson RM, May RM (1991) Infectious diseases of humans: dynamics and control. Oxford; New York: Oxford University Press. viii, 757 p.
20. Gravenor MB, McLean AR, Kwiatkowski D, (1995) The regulation of malaria parasitaemia: parameter estimates for a population model. Parasitology 110 (Pt 2): 115-122.
21. Anderson RM, May RM, Gupta S, (1989) Non-linear phenomena in host-parasite interactions. Parasitology 99 (Suppl) S59-79.
22. Kwiatkowski D, Nowak M, (1991) Periodic and chaotic host-parasite interactions in human malaria. Proc Natl Acad Sci U S A 88: 5111-5113.
23. Hetzel C, Anderson RM, (1996) The within-host cellular dynamics of bloodstage malaria: theoretical and experimental studies. Parasitology 113 (Pt 1): 25-38.
24. Austin DJ, White NJ, Anderson RM, (1998) The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics. J Theor Biol 194: 313-339.
25. Saul A, (1998) Models for the in-host dynamics of malaria revisited: errors in some basic models lead to large over-estimates of growth rates. Parasitology 117: 405-407.
26. Collins WE, Jeffery GM, (1999) A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during primary infection. Am J Trop Med Hyg 61: 4-19.
27. Paget-McNicol S, Gatton M, Hastings I, Saul A, (2002) The Plasmodium falciparum var gene switching rate, switching mechanism and patterns of parasite recrudescence described by mathematical modelling. Parasitology 124: 225-235.
28. Smith T, Maire N, Ross A, Penny M, Chitnis N, et al. (2008) Towards a comprehensive simulation model of malaria epidemiology and control. Parasitology 135: 1507-1516.
29. Collins WE, Jeffery GM, (1999) A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am J Trop Med Hyg 61: 20-35.
30. Collins WE, Jeffery GM, (1999) A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. Am J Trop Med Hyg 61: 36-43.
31. Collins WE, Jeffery GM, (1999) A retrospective examination of the patterns of recrudescence in patients infected with Plasmodium falciparum. Am J Trop Med Hyg 61: 44-48.
32. Sama W, Killeen G, Smith T, (2004) Estimating the duration of Plasmodium falciparum infection from trials of indoor residual spraying. Am J Trop Med Hyg 70: 625-634.
33. Recker M, Nee S, Bull PC, Kinyanjui S, Marsh K, et al. (2004) Transient cross-reactive immune responses can orchestrate antigenic variation in malaria. Nature 429: 555-558.
34. Douglas AD, Williams AR, Illingworth JJ, Kamuyu G, Biswas S, et al. (2011) The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun 2: 601.
35. Horrocks P, Pinches R, Christodoulou Z, Kyes SA, Newbold CI, (2004) Variable var transition rates underlie antigenic variation in malaria. Proceedings of the National Academy of Sciences of the United States of America 101: 11129-11134.
36. Sinden RE, Butcher GA, Billker O, Fleck SL, (1996) Regulation of Infectivity of Plasmodium to the Mosquito Vector. Advances in Parasitology 38: 53-117.
37. Ross A, Killeen G, Smith T, (2006) Relationships Between Host Infectivity to Mosquitoes and Asexual Parasite Density in Plasmodium falciparum. Am J Trop Med Hyg 75: 32-37.
38. Jeffery GM, Eyles DE, (1955) Infectivity to Mosquitoes of Plasmodium Falciparum as Related to Gametocyte Density and Duration of Infection. Am J Trop Med Hyg 4: 781-789.
39. Naotunne TS, Karunaweera ND, Del Giudice G, Kularatne MU, Grau GE, et al. (1991) Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. The Journal of Experimental Medicine 173: 523-529.
40. Naotunne TS, Karunaweera ND, Mendis KN, Carter R, (1993) Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology 78: 555-562.
41. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C, (1999) Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 5: 340-343.
42. Tami A, Ord R, Targett GA, Sutherland CJ, (2003) Sympatric Plasmodium falciparum isolates from Venezuela have structured var gene repertoires. Malar J 2: 7.
43. Aguiar JC, Albrecht GR, Cegielski P, Greenwood BM, Jensen JB, et al. (1992) Agglutination of Plasmodium falciparum-Infected Erythrocytes from East and West African Isolates by Human Sera from Distant Geographic Regions. Am J Trop Med Hyg 47: 621-632.
44. Verra F, Hughes AL, (1999) Natural selection on apical membrane antigen-1 of Plasmodium falciparum. Parassitologia 41: 93-95.
45. Baird JK, (1998) Age dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Annals of Tropical Medicine and Parasitology 92: 367-390.
46. White L, Maude R, Pongtavornpinyo W, Saralamba S, Aguas R, et al. (2009) The role of simple mathematical models in malaria elimination strategy design. Malaria Journal 8: 212.
47. Maude R, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, et al. (2009) The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malaria Journal 8: 31.
48. Lange A, Ferguson NM, (2009) Antigenic Diversity, Transmission Mechanisms, and the Evolution of Pathogens. PLoS Comput Biol 5: e1000536.
49. Eckhoff P, (2011) A malaria transmission-directed model of mosquito life cycle and ecology. Malaria Journal 10: 303.
50. Miller LH, Baruch DI, Marsh K, Doumbo OK, (2002) The pathogenic basis of malaria. Nature 415: 673-679.
51. Langhorne J, Ndungu FM, Sponaas AM, Marsh K, (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725-732.
52. Ndungu FM, Urban BC, Marsh K, Langhorne J, (2005) Regulation of immune response by Plasmodium-infected red blood cells. Parasite Immunol 27: 373-384.
53. Xu H, Wipasa J, Yan H, Zeng M, Makobongo MO, et al. (2002) The Mechanism and Significance of Deletion of Parasite-specific CD4+ T Cells in Malaria Infection. J Exp Med 195: 881-892.
54. Okell L, Drakeley C, Ghani A, Bousema T, Sutherland C, (2008) Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malaria Journal 7: 125.
55. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC (2008) Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med 5: e226; discussion e226.
56. Penny MA, Maire N, Studer A, Schapira A, Smith TA, (2008) What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines. PLoS ONE 3: e3193.
57. Bruce MC, Day KP, (2003) Cross-species regulation of Plasmodium parasitemia in semi-immune children from Papua New Guinea. 19: 271-277.
58. Frischknecht F, Baldacci P, Martin B, Zimmer C, Thiberge S, et al. (2004) Imaging movement of malaria parasites during transmission by Anopheles mosquitoes. Cell Microbiol 6: 687-694.
59. Beier JC, Davis JR, Vaughan JA, Noden BH, Beier MS, (1991) Quantitation of Plasmodium falciparum Sporozoites Transmitted in Vitro by Experimentally Infected Anopheles gambiae and Anopheles stephensi. Am J Trop Med Hyg 44: 564-570.
60. Sinden RE, Matuschewski K (2005) The Sporozoite. In: Sherman IW, editor. Molecular Approaches to Malaria. Washington DC: ASM Press. 169-190.
61. Cheng Q, Lawrence G, Reed C, Stowers A, Ranford-Cartwright L, et al. (1997) Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines. Am J Trop Med Hyg 57: 495-500.
62. Smith DL, McKenzie FE, Snow RW, Hay SI, (2007) Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol 5: e42.
63. Smith DL, Dushoff J, Snow RW, Hay SI, (2005) The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature 438: 492-495.
64. Galinski MR, Dluzewski AR, Barnwell JW (2005) A Mechanistic Approach to Merozoite Invasion of Red Blood Cells: Merozoite Biogenesis, Rupture, and Invasion of Erythrocytes. In: Sherman IW, editor. Molecular Approaches to Malaria. Washington DC: ASM Press. 113-168.
65. Lawrence G, Cheng QQ, Reed C, Taylor D, Stowers A, et al. (2000) Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. Vaccine 18: 1925-1931.
66. Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, et al. (1995) Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82: 77-87.
67. Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, et al. (1995) The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 82: 89-100.
68. Horrocks P, Kyes SA, Bull PC, Deitsch KW (2005) Molecular Aspects of Antigenic Variation in Plasmodium falciparum. In: Sherman IW, editor. Molecular Approaches to Malaria. Washington DC: ASM Press. 399-415.
69. Roberts DJ, Craig AG, Berendt AR, Pinches R, Nash G, et al. (1992) Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357: 689-692.
70. Recker M, Buckee CO, Serazin A, Kyes S, Pinches R, et al. (2011) Antigenic Variation in Plasmodium falciparum Malaria Involves a Highly Structured Switching Pattern. PLoS Pathog 7: e1001306.
71. Sinden RE, (2009) Malaria, sexual development and transmission: retrospect and prospect. Parasitology 136: 1427-1434.
72. Alano P, Billker O (2005) Gametocytes and Gametes. In: Sherman IW, editor. Molecular Approaches to Malaria. Washington DC: ASM Press. 191-219.
73. Cooke BM, Coppel RL, (1995) Cytoadhesion and falciparum malaria: going with the flow. Parasitol Today 11: 282-287.
74. Thomson JG, Robertson A, (1935) The structure and development of Plasmodium falciparum gametocytes in the internal organs and in the peripheral circulation. Trans R Soc Trop Med Hyg 29: 31-40.
75. Smalley ME, Sinden RE, (1977) Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 74: 1-8.
76. Billker O, Lindo V, Panico M, Etienne AE, Paxton T, et al. (1998) Identification of xanthurenic acid as the putative inducer of malaria development in the mosquito. Nature 392: 289-292.
77. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, et al. (2007) Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg 76: 470-474.
78. Bonnet S, Gouagna C, Safeukui I, Meunier J-Y, Boudin C, (2000) Comparison of artificial membrane feeding with direct skin feeding to estimate infectiousness of Plasmodium falciparum gametocyte carriers to mosquitoes. Transactions of the Royal Society of Tropical Medicine and Hygiene 94: 103-106.
79. Al-Olayan EM, Beetsma AL, Butcher GA, Sinden RE, Hurd H, (2002) Complete Development of Mosquito Phases of the Malaria Parasite in Vitro. Science 295: 677-679.
80. Sinden RE, (1999) Plasmodium differentiation in the mosquito. Parassitologia 41: 139-148.
81. Renia L, Rodrigues MM, Nussenzweig V, (1994) Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage. Immunology 82: 164-168.
82. Doolan DL, Hoffman SL, (1999) IL-12 and NK Cells Are Required for Antigen-Specific Adaptive Immunity Against Malaria Initiated by CD8+ T Cells in the Plasmodium yoelii Model. J Immunol 163: 884-892.
83. Stevenson MM, Riley EM, (2004) Innate immunity to malaria. Nat Rev Immunol 4: 169-180.
84. Mohan K, Moulin P, Stevenson M, (1997) Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J Immunol 159: 4990-4998.
85. Kochin BF, Yates AJ, de Roode JC, Antia R, (2010) On the Control of Acute Rodent Malaria Infections by Innate Immunity. PLoS ONE 5: e10444.
86. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, et al. (2005) Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 201: 19-25.
87. Scragg IG, Hensmann M, Bate CAW, Kwiatkowski D, (1999) Early cytokine induction by Plasmodium falciparum is not a classical endotoxin-like process. European Journal of Immunology 29: 2636-2644.
88. Artavanis-Tsakonas K, Riley EM, (2002) Innate Immune Response to Malaria: Rapid Induction of IFN-{gamma} from Human NK Cells by Live Plasmodium falciparum-Infected Erythrocytes. J Immunol 169: 2956-2963.
89. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, et al. (1993) Anti-TNF therapy inhibits fever in cerebral malaria. QJM 86: 91-98.
90. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, et al. (1998) Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med 4: 358-360.
91. Naik RS, Branch OH, Woods AS, Vijaykumar M, Perkins DJ, et al. (2000) Glycosylphosphatidylinositol Anchors of Plasmodium falciparum: Molecular Characterization and Naturally Elicited Antibody Response That May Provide Immunity to Malaria Pathogenesis. J Exp Med 192: 1563-1576.
92. Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, et al. (1998) Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351: 1768-1772.
93. Peyron F, Burdin N, Ringwald P, Vuillez JP, Rousset F, et al. (1994) High levels of circulating IL-10 in human malaria. Clinical & Experimental Immunology 95: 300-303.
94. Omer FM, de Souza JB, Riley EM, (2003) Differential Induction of TGF-{beta} Regulates Proinflammatory Cytokine Production and Determines the Outcome of Lethal and Nonlethal Plasmodium yoelii Infections. J Immunol 171: 5430-5436.
95. Omer FM, Riley EM, (1998) Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J Exp Med 188: 39-48.
96. Ofori MF, Dodoo D, Staalsoe T, Kurtzhals JAL, Koram K, et al. (2002) Malaria-Induced Acquisition of Antibodies to Plasmodium falciparum Variant Surface Antigens. Infect Immun 70: 2982-2988.
97. Bull PC, Marsh K, (2002) The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. TRENDS in Microbiology 10: 55-58.
98. Langhorne J, Quin SJ, Sanni LA, (2002) Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem Immunol 80: 204-228.
99. Holder AA, Patino JAG, Uthaipibull C, Syed SE, Ling IT, et al. (1999) Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parassitologia 41: 409-414.
100. Mount AM, Mwapasa V, Elliott SR, Beeson JG, Tadesse E, et al. (2004) Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. The Lancet 363: 1860-1867.
101. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA, (1990) A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 172: 379-382.
102. Fowkes FJI, Richards JS, Simpson JA, Beeson JG, (2010) The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis. PLoS Med 7: e1000218.
103. Dorfman Jeffrey R, Bejon P, Ndungu Francis M, Langhorne J, Kortok Moses M, et al. (2005) B Cell Memory to 3 Plasmodium falciparum Blood-Stage Antigens in a Malaria-Endemic Area. The Journal of Infectious Diseases 191: 1623-1630.
104. Migot F, Chougnet C, Raharimalala L, Astagneau P, Lepers J-P, et al. (1993) Human Immune Responses to the Plasmodium Falciparum Ring-Infected Erythrocyte Surface Antigen (Pf155/RESA) after a Decrease in Malaria Transmission in Madagascar. Am J Trop Med Hyg 48: 432-439.
105. Yoneto T, Yoshimoto T, Wang C-R, Takahama Y, Tsuji M, et al. (1999) Gamma Interferon Production Is Critical for Protective Immunity to Infection with Blood-Stage Plasmodium berghei XAT but Neither NO Production nor NK Cell Activation Is Critical. Infect Immun 67: 2349-2356.
106. Langreth SG, Peterson E, (1985) Pathogenicity, stability, and immunogenicity of a knobless clone of Plasmodium falciparum in Colombian owl monkeys. Infect Immun 47: 760-766.
107. Jafarshad A, Dziegiel MH, Lundquist R, Nielsen LK, Singh S, et al. (2007) A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes Fc{gamma}RII and Fc{gamma}RIII. J Immunol 178: 3099-3106.